Sciele backs out of Victory Pharma deal

Citing an "unforeseen development" that occurred after the deal was signed, Shionogi & Co said its subsidiary Sciele Pharma would not go through will its planned buyout of Victory Pharma. In May, Sciele announced it would buy Victory for $150 million. According to a release, the decision to cancel the deal was mutual. Shionogi's release